What is Kesimpta, injection solution in Fertigpen used for?

( ARTG ) Kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) to delay the progression of physical disability and reduce the frequency of relapse (refer to section 5.1).

What are the side effects of Kesimpta, injection solution in Fertigpen?

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems . For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

Can Kesimpta, injection solution in Fertigpen be used during pregnancy?

( AHT ) For the active ingredient ofatumumab You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Who manufactures Kesimpta, injection solution in Fertigpen?

Novartis Pharma Schweiz AG (CH)

What ATC class does Kesimpta, injection solution in Fertigpen belong to?

Kesimpta, injection solution in Fertigpen: ATC L04AG12. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Kesimpta, injection solution in Fertigpen

INN: X

Data updated: 2026-04-11

Available in:

🇨🇿🇩🇪🇬🇧🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Novartis Pharma Schweiz AG

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.